Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.40
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 24.00
High: 24.40
Low: 24.00
Prev. Close: 23.00
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Base Resources profit surges; Spectral MD optimistic

Mon, 27th Feb 2023 14:27

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Base Resources Ltd - Australia-based, Africa-focused mineral sands producer - Pretax profit in the six months to December 31 jumps to USD64.8 million from USD29.1 million a year prior. Revenue climbs 21% to USD126.6 million from USD104.6 million. Company cites price improvements for all products and strong markets for mineral sands. Cost of sales decrease 18% to USD48.8 million from USD59.3 million. Lowers interim dividend by 33% to 2 Australian cents per share from 3 Australian cents per share a year ago. Anticipates Western pigment producers to increase production rate "back to normal levels through the second half of financial year 2023". Further, is optimistic on China after it eased its Covid restrictions last month.

----------

Beeks Financial Cloud Group PLC - Glasgow-based cloud computing and connectivity provider - Pretax loss in the half-year to December 31 widens to GBP762,000 from GBP266,000 a year prior. Revenue grows 35% to GBP10.4 million from GBP7.7 million. Cost of sales widens 24% to GBP6.2 million from GBP5.0 million. Administrative expenses increase 60% to GBP4.9 million from GBP3.1 million. Depreciation increases to GBP2.1 million from GBP1.5 million, as cost of share-based payments widen to GBP1.2 million from GBP414,000. Looking ahead, Chief Executive Officer Gordon McArthur said: "Our principal focus for the second half will be to convert our substantial pipeline of opportunities across the newly launched Exchange Cloud offering. While the macro environment presents challenges to all businesses, we believe the shift of the financial services sector to cloud computing will continue at pace."

----------

Global Invacom Group Ltd - Singapore-based satellite communications equipment and electronics provider - Annual loss in 2022 balloons to USD12.2 million from USD28,000 in 2021. Revenue falls 12% to USD72.8 million from USD82.5 million. Cost of sales widen 10% to USD59.4 million from USD66.0 million. Notes one-off impairment of goodwill of USD5.2 million for 2022. Global Invacom explained that it was non-cash in nature and related to the performance of its US subsidiary. Company expects "considerable macroeconomic headwinds" which impacted it in 2022 to continue in 2023. Looking ahead, Global Invacom said: "In order to establish long-term growth, and as part of its operational restructuring, Global Invacom remains committed to technological innovation and development. By working in collaboration with key customers, the group is well positioned to maintain its reputation of developing best-in-class solutions for the satellite industry."

----------

Oncimmune Holdings PLC - Nottingham-based immuno-diagnostics developer - In the 15 months to August 31, revenue was GBP3.8 million, little changed from GBP3.7 million in the year to May 31. Pretax loss widens to GBP11.6 million from GBP6.1 million across the same time frame. Administrative expenses widen 54% to GBP8.7 million from GBP5.7 million, as cost of sales more than doubles to GBP2.0 million from GBP865,000. However, says revenue in the first six months of financial 2023 is expected to exceed GBP3.8 million, and it expects to be operating cashflow positive during the year.

----------

Quartix Technologies PLC - Newtown, Wales-based vehicle tracking system provider - Pretax profit in 2022 climbs 2.4% to GBP5.5 million from GBP5.4 million a year ago. Revenue grows 7.9% to GBP27.5 million from GBP25.5 million. Proposes final dividend of 6.30p, down 10% from 7.00p a year ago. Total dividend for 2022 is 7.80p, 8.2% lower than 8.50p a year prior. Looking ahead, it says: "The group has made a strong start to the year, with new installations in January ahead of the same period in 2022; however the company notes that this may not extrapolate to Q1 year on year performance due to an exceptionally higher March 2022 performance." Quartix adds that intends to continue to invest a proportion of its gross profit on sales and marketing "to further develop the profitable subscription platform it has created by accelerating growth in its fleet subscription base."

----------

Spectral MD Holdings Ltd - Dallas, Texas-based predictive analytics company focused on algorithms and technology that allow for fast and more accurate treatment decisions - Pretax loss in 2022 narrows 31% to USD2.8 million from USD4.1 million in 2021. Research & Development revenue jumps 66% to USD25.4 million from USD15.2 million. Cost of revenue widens 77% to USD14.5 million from USD8.2 million. Looking ahead, the company plans to complete pre-submission to the US Food & Drug Administration to achieve alignment on the burn validation study protocol, regarding its Burn artificial intelligence training study. Regarding the UK, it adds it "is evaluating an accelerated UK regulatory submission pathway for 2023." Chief Executive Officer Wensheng Fan says: "Our immediate strategy remains focused on commercialization planning activities. We are in regular communication with Biomedical Advanced Research & Development Authority to further develop our infrastructure readiness for a federal level commercial contract and look forward to building upon our strong momentum, whilst continuing to collaborate with BARDA and our clinical partners to scale and advance our transformative technology." BARDA is a US Department of Health & Human Services office.

----------

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Feb 2024 17:00

EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 13:04

Oncimmune revenue falls as it implements new strategy

(Sharecast News) - Oncimmune reported revenue of £2.1m in its final results on Thursday, down from £3.8m for the prior extended 15-month period, with revenue from continuing operations totalling £1.2m.

Read more
19 Feb 2024 12:54

UK shareholder meetings calendar - next 7 days

Tuesday 20 February 
abrdn Equity Income Trust PLCAGM
Carr's Group PLCAGM
Dewhurst Group PLCAGM
Duke Royalty LtdEGM re changing name to Duke Capital
Wednesday 21 February 
Foresight Sustainable Forestry Co PLCAGM
Gooch & Housego PLCAGM
Tharisa PLCAGM
Thursday 22 February 
Bankers Investment Trust PLCAGM
Narf Industries PLCAGM
RWS Holdings PLCAGM
Sunrise Resources PLCAGM
Friday 23 February 
Blencowe Resources PLCAGM
Bluebird Merchant Ventures LtdAGM
Caledonian Trust PLCAGM
Chemring Group PLCAGM
Marble Point Loan Financing LtdEGM
Monday 26 February 
Oncimmune Holdings PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
30 Nov 2023 14:25

TRADING UPDATES: SkinBio launches food supplement on Amazon

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
12 Oct 2023 14:21

IN BRIEF: Oncimmune shares jump following new strategy update

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Announces plans to focus on higher value customers, penetrating key accounts, partnering with key technology suppliers and launching new tools. Intends to accelerate new commercial contracts through partnerships with more contract research organisations to expand customer base, leverage auto-antibody analysis capabilities across new areas like companion diagnostics, and augment its commercial team. Also plans to expand its business models "beyond price-per-sample to more strategic partnership models" with upfront project and milestone success fees to better reflect its value. Update follows the disposal of Oncimmune Ltd in May, and the hiring of Martin Gouldstone as chief executive officer and Martin Hudson as finance director in August and September respectively. Company says final results for year ended August 31 will be released in due course.

Read more
12 Jul 2023 11:14

Oncimmune names chief executive successor, while finance chief leaves

(Alliance News) - Oncimmune Holdings PLC on Wednesday said it appointed Martin Gouldstone as its new chief executive, replacing Adam Hill who stepped down following the divestment of Oncimmune Ltd.

Read more
23 Jun 2023 12:08

Oncimmune Holdings shakes up leadership and unveils new growth plan

(Alliance News) - Oncimmune Holdings PLC on Friday said its chief executive officer will step down, as it unveiled a new plan for delivering refocused growth.

Read more
31 May 2023 13:31

Oncimmune shares plummet as interim revenue falls by fifth

(Alliance News) - Oncimmune Holdings PLC on Wednesday said revenue was down in the first half of its financial year due to delivery delays, but its loss narrowed.

Read more
22 May 2023 14:22

Oncimmune sells two subsidiaries to Freenome for GBP13 million

(Alliance News) - Oncimmune Holdings PLC on Monday said it has sold its subsidiaries Oncimmune Ltd and Oncimmune Europe GmbH to Freenome Holdings Inc, for GBP13 million in cash.

Read more
22 May 2023 11:14

Oncimmune sells 'non-core' lung and antibody assets in £13m deal

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced the sale of its wholly-owned subsidiaries Oncimmune Limited and Oncimmune Europe to the US-based, privately-held Freenome Holdings on Monday.

Read more
22 May 2023 10:12

AIM WINNERS & LOSERS: Lansdowne and Barryroe slump after licence blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Mar 2023 15:54

UK shareholder meetings calendar - next 7 days

Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Blackrock Throgmorton Trust PLCAGM
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
LPA Group PLCAGM
Zaim Credit Systems PLCGM re director removal and name change to Adalan Ventures PLC
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
Quartix Technologies PLCAGM
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
Monday 27 March 
Let's Explore Group PLCGM re off-market purchase of the company's ordinary shares 
Oncimmune Holdings PLCGM re directors' remuneration
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Feb 2023 10:37

AIM WINNERS & LOSERS: Elixirr meets guidance, in strong start to 2023

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Feb 2023 15:49

UK shareholder meetings calendar - next 7 days

Tuesday 21 February 
Blue Planet Investment Trust PLCGM re voluntary liquidation
Immotion Group PLCGM re proposed sales and name change
Schroder UK Mid Cap Fund PLCAGM
Virgin Money UK PLCAGM
Wednesday 22 February 
Barkby Group PLCAGM
Gooch & Housego PLCAGM
Itaconix PLCGM re open offer shares
RWS Holdings PLCAGM
Tharisa PLCAGM
Thursday 23 February 
Bankers Investment Trust PLCAGM
Foresight Sustainable Forestry Co PLCAGM
IntegraFin Holdings PLCAGM
Friday 24 February 
Caledonian Trust PLCAGM
Ediston Property Investment Co PLCAGM
Monday 27 February 
Bonhill Group PLCGM re proposed capital reduction
Carr's Group PLCAGM
Diversified Energy Co PLCGM re capital raise and proposed acquisition
Oncimmune Holdings PLCAGM
Ramsdens Holdings PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.